VULLO, DANIELA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 27.864
EU - Europa 11.367
AS - Asia 7.990
SA - Sud America 1.827
AF - Africa 313
Continente sconosciuto - Info sul continente non disponibili 251
OC - Oceania 172
Totale 49.784
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 27.570
RU - Federazione Russa 3.412
IT - Italia 2.615
PL - Polonia 2.302
SG - Singapore 2.248
CN - Cina 1.639
BR - Brasile 1.502
HK - Hong Kong 1.281
VN - Vietnam 1.097
IE - Irlanda 987
KR - Corea 787
SE - Svezia 620
FI - Finlandia 354
FR - Francia 322
IN - India 276
DE - Germania 265
GB - Regno Unito 198
AU - Australia 168
CA - Canada 160
TR - Turchia 134
AR - Argentina 122
CI - Costa d'Avorio 101
BD - Bangladesh 98
ES - Italia 88
UA - Ucraina 84
ID - Indonesia 77
NG - Nigeria 64
IQ - Iraq 58
MX - Messico 56
JP - Giappone 54
EC - Ecuador 53
PY - Paraguay 36
ZA - Sudafrica 36
CO - Colombia 35
PK - Pakistan 34
JO - Giordania 32
MA - Marocco 30
NL - Olanda 27
VE - Venezuela 25
SA - Arabia Saudita 21
EG - Egitto 20
CL - Cile 19
TN - Tunisia 18
BE - Belgio 17
PE - Perù 17
TW - Taiwan 17
UZ - Uzbekistan 17
PH - Filippine 16
JM - Giamaica 12
KE - Kenya 11
UY - Uruguay 11
AZ - Azerbaigian 10
CR - Costa Rica 10
KZ - Kazakistan 10
SV - El Salvador 10
AE - Emirati Arabi Uniti 9
DZ - Algeria 9
LT - Lituania 9
NP - Nepal 9
TT - Trinidad e Tobago 9
CH - Svizzera 8
PS - Palestinian Territory 8
BG - Bulgaria 7
BO - Bolivia 7
IL - Israele 7
OM - Oman 7
AT - Austria 6
NI - Nicaragua 6
AL - Albania 5
CZ - Repubblica Ceca 5
DO - Repubblica Dominicana 5
ET - Etiopia 5
GT - Guatemala 5
HN - Honduras 5
MY - Malesia 5
PA - Panama 5
PT - Portogallo 5
QA - Qatar 5
SN - Senegal 5
BA - Bosnia-Erzegovina 4
IR - Iran 4
KG - Kirghizistan 4
LB - Libano 4
MU - Mauritius 4
NO - Norvegia 4
PR - Porto Rico 4
AM - Armenia 3
BJ - Benin 3
BY - Bielorussia 3
EU - Europa 3
GE - Georgia 3
MD - Moldavia 3
MK - Macedonia 3
MN - Mongolia 3
NZ - Nuova Zelanda 3
RO - Romania 3
TH - Thailandia 3
BB - Barbados 2
EE - Estonia 2
GA - Gabon 2
Totale 49.506
Salva come PNG Salva come JPEG
Città #
Fairfield 4.261
Ashburn 3.596
Santa Clara 3.343
Warsaw 2.300
Woodbridge 2.126
Seattle 1.835
Cambridge 1.662
Singapore 1.581
Houston 1.566
Wilmington 1.281
Hong Kong 998
Dublin 983
Seoul 781
Chandler 698
Milan 572
Ann Arbor 563
Lawrence 508
Altamura 504
San Jose 457
Princeton 423
Ho Chi Minh City 358
The Dalles 331
Beijing 298
Lauterbourg 277
Hefei 271
Los Angeles 245
Hanoi 230
Rome 217
Boston 180
Jacksonville 175
Medford 173
Melbourne 166
Boardman 164
Florence 163
Buffalo 156
San Diego 152
Moscow 150
Mumbai 149
Clifton 127
Dallas 126
São Paulo 114
Council Bluffs 105
Abidjan 101
New York 80
Dong Ket 78
Redondo Beach 75
Barcelona 72
Falls Church 72
Naples 69
Turin 69
Helsinki 63
Abuja 60
Norwalk 56
Izmir 54
Figino 51
Kent 50
Munich 49
Shanghai 47
Da Nang 46
Rio de Janeiro 44
Bologna 42
Jakarta 42
Tokyo 41
Belo Horizonte 39
Guangzhou 39
Palermo 39
Toronto 39
Phoenix 38
Wuhan 38
Chicago 37
Miano 37
London 36
Brasília 35
Frankfurt am Main 34
Hillsboro 33
Haiphong 31
Orem 31
Andover 30
Brooklyn 26
Paris 26
Campinas 22
Düsseldorf 22
Baghdad 21
Catania 20
Quito 19
Yubileyny 19
Asunción 18
Atlanta 18
Curitiba 18
Hải Dương 18
Ninh Bình 18
Ribeirão Preto 18
Bengaluru 17
Dearborn 17
Dhaka 17
Genoa 17
Tianjin 17
Venice 17
Brescia 16
Brussels 16
Totale 36.579
Salva come PNG Salva come JPEG
Nome #
Ureido-Substituted Benzenesulfonamides Potently Inhibit Carbonic Anhydrase IX and Show Antimetastatic Activity in a Model of Breast Cancer Metastasis 380
Carbonic anhydrases activation with 3-amino-1H-1,2,4-triazole-1-carboxamides: Discovery of subnanomolar isoform II activators 317
Modification of carbonic anhydrase II with acetaldehyde, the first metabolite of ethanol, leads to decreased enzyme activity. 316
Sulfonamide inhibition studies of the γ-carbonic anhydrase from the Antarctic bacterium Pseudoalteromonas haloplanktis 307
Anion inhibition studies of a beta carbonic anhydrase from the malaria mosquito Anopheles gambiae 302
Sulfonamide inhibition profile of the γ-carbonic anhydrase identified in the genome of the pathogenic bacterium Burkholderia pseudomallei the etiological agent responsible of melioidosis 300
Natural product polyamines that inhibit human carbonic anhydrases 299
Carbonic Anhydrase Activators: Gold Nanoparticles Coated with Derivatized Histamine, Histidine, and Carnosine Show Enhanced Activatory Effects on Several Mammalian Isoforms. 291
Mapping Selective Inhibition of the Cancer-Related Carbonic Anhydrase IX Using Structure-Activity Relationships of Glucosyl-Based Sulfamates 286
Ethylene bis-imidazoles are highly potent and selective activators for isozymes VA and VII of carbonic anhydrase, with a potential nootropic effect 281
7-Amino-3,4-dihydro-1H-quinolin-2-one, a compound similar to the substituted coumarins, inhibits α-carbonic anhydrases without hydrolysis of the lactam ring. 278
Ascaris lumbricoides β carbonic anhydrase: A potential target enzyme for treatment of ascariasis 278
Ferrier sulfamidoglycosylation of glycals catalyzed by nitrosonium tetrafluoroborate: Towards new carbonic anhydrase glycoinhibitors 277
Natural product coumarins that inhibit human carbonic anhydrases. 273
Crystal structure and kinetic studies of a tetrameric type II β-carbonic anhydrase from the pathogenic bacterium Vibrio cholerae 272
Mono-/dihydroxybenzoic acid esters and phenol pyridinium derivatives as inhibitors of the mammalian carbonic anhydrase isoforms I, II, VII, IX, XII and XIV. 270
S-glycosyl primary sulfonamides--a new structural class for selective inhibition of cancer-associated carbonic anhydrases. 261
Dithiocarbamates with potent inhibitory activity against the Saccharomyces cerevisiae β-carbonic anhydrase 258
1,2-Benzisothiazole Derivatives Bearing 4-, 5-, or 6-Alkyl/arylcarboxamide Moieties Inhibit Carbonic Anhydrase Isoform IX (CAIX) and Cell Proliferation under Hypoxic Conditions 247
Synthesis of new 3-(2-mercapto-4-oxo-4H-quinazolin-3-yl)-benzenesulfonamides with strong inhibition properties against the tumor associated carbonic anhydrases IX and XII 236
Inhibition of the β-carbonic anhydrase from Streptococcus pneumoniae by inorganic anions and small molecules: Toward innovative drug design of antiinfectives? 235
PET Imaging of Carbonic Anhydrase IX Expression of HT-29 Tumor Xenograft Mice with 68Ga-Labeled Benzenesulfonamides 233
Biochemical characterization of the δ-carbonic anhydrase from the marine diatom Thalassiosira weissflogii, TweCA 231
Carbonic anhydrase activation enhances object recognition memory in mice through phosphorylation of the extracellular signal-regulated kinase in the cortex and the hippocampus. 227
A Divalent PAMAM-Based Matrix Metalloproteinase/Carbonic Anhydrase Inhibitor for the Treatment of Dry Eye Syndrome 205
In vitro inhibition of Mycobacterium tuberculosis β-carbonic anhydrase 3 with Mono- and dithiocarbamates and evaluation of their toxicity using zebrafish developing embryos 204
A substituted sulfonamide and its Co (II), Cu (II), and Zn (II) complexes as potential antifungal agents 202
Activation Profile Analysis of CruCA4, an α-Carbonic Anhydrase Involved in Skeleton Formation of the Mediterranean Red Coral, Corallium rubrum 201
Biochemical characterization of recombinant β-carbonic anhydrase (PgiCAb) identified in the genome of the oral pathogenic bacterium Porphyromonas gingivalis 201
Structure-based screening for the discovery of new carbonic anhydrase VII inhibitors 199
Synthesis and evaluation of carbonic anhydrase inhibitors with carbon monoxide releasing properties for the management of rheumatoid arthritis 196
Potent and Selective Carboxylic Acid Inhibitors of Tumor-Associated Carbonic Anhydrases IX and XII 196
Anion inhibition profiles of the γ-carbonic anhydrase from the pathogenic bacterium Burkholderia pseudomallei responsible of melioidosis and highly drug resistant to common antibiotics 194
Anion inhibition studies of the fastest carbonic anhydrase (CA) known, the extremo-CA from the bacterium Sulfurihydrogenibium azorense. 190
Analysis of a shortened form of human carbonic anhydrase VII expressed in vitro compared to the full-length enzyme. 190
Biochemical characterization of the native α-carbonic anhydrase purified from the mantle of the Mediterranean mussel, Mytilus galloprovincialis 189
Design and validation of FRESH, a drug discovery paradigm resting on robust chemical synthesis 188
Plasmonic Particles that Hit Hypoxic Cells 188
A computer-assisted discovery of novel potential anti-obesity compounds as selective carbonic anhydrase VA inhibitors 188
Anion inhibition profiles of the complete domain of the η-carbonic anhydrase from Plasmodium falciparum 188
A new procedure for the cloning, expression and purification of the β-carbonic anhydrase from the pathogenic yeast Malassezia globosa, an anti-dandruff drug target 187
Comparison of the Sulfonamide Inhibition Profiles of the β- and γ-Carbonic Anhydrases from the Pathogenic Bacterium Burkholderia pseudomallei 187
4-Functionalized 1,3-diarylpyrazoles bearing benzenesulfonamide moiety as selective potent inhibitors of the tumor associated carbonic anhydrase isoforms IX and XII 186
Carbonic anhydrase inhibitors. Inhibition of the human cytosolic isozyme VII with aromatic and heterocyclic sulfonamides. 185
Restoring catalytic activity to the human carbonic anhydrase (CA) related proteins VIII, X and XI affords isoforms with high catalytic efficiency and susceptibility to anion inhibition. 184
Carbonic anhydrase inhibitors. Inhibition studies of the human secretory isoform VI with anions. 183
New β-arylchalcogeno amines with procognitive properties targeting Carbonic Anhydrases and Monoamine Oxidases 181
Carbonic anhydrase inhibitors: inhibition of transmembrane, tumor-associated isozyme IX, and cytosolic isozymes I and II with aliphatic sulfamates. 180
Active components of essential oils as anti-obesity potential drugs investigated by in silico techniques 180
Carbonic anhydrase inhibitors. Cloning, characterization and inhibition studies of the cytosolic isozyme III with anions. 180
A new β-carbonic anhydrase from Brucella suis, its cloning, characterization, and inhibition with sulfonamides and sulfamates, leading to impaired pathogen growth. 180
Inhibition of carbonic anhydrase isozymes I, II and IX with benzenesulfonamides containing an organometallic moiety. 179
Carbonic anhydrase activators. Activation of isozymes I, II, IV, VA, VII, and XIV with l- and d-histidine and crystallographic analysis of their adducts with isoform II: engineering proton-transfer processes within the active site of an enzyme. 178
Carbonic anhydrase inhibitors. DNA cloning, characterization, and inhibition studies of the human secretory isoform VI, a new target for sulfonamide and sulfamate inhibitors. 178
In Vivo Evaluation of Selective Carbonic Anhydrase Inhibitors as Potential Anticonvulsant Agents 178
An anion and small molecule inhibition study of the β-carbonic anhydrase from Staphylococcus aureus 178
Cyclic tertiary sulfamates: Selective inhibition of the tumor-associated carbonic anhydrases IX and XII by N- and O-substituted acesulfame derivatives 177
Synthesis of a new series of dithiocarbamates with effective human carbonic anhydrase inhibitory activity and antiglaucoma action 177
Carbonic anhydrase inhibitors: glycosylsulfanilamides act as subnanomolar inhibitors of the human secreted isoform VI. 176
Carbonic anhydrase inhibitors. Inhibition of tumor-associated isozyme IX by halogenosulfanilamide and halogenophenylaminobenzolamide derivatives. 176
Carbonic anhydrase activators: activation of isozyme XIII with amino acids and amines. 176
3-phenyl-1H-indole-5-sulfonamides: structure-based drug design of a promising class of carbonic anhydrase inhibitors. 176
Design and Synthesis of Novel Nonsteroidal Anti-Inflammatory Drugs and Carbonic Anhydrase Inhibitors Hybrids (NSAIDs-CAIs) for the Treatment of Rheumatoid Arthritis 176
Pyridinium derivatives of histamine are potent activators of cytosolic carbonic anhydrase isoforms I, II and VII. 175
5-Substituted-benzylsulfanyl-thiophene-2-sulfonamides with effective carbonic anhydrase inhibitory activity: Solution and crystallographic investigations 175
Carbonic anhydrase inhibitors: inhibition of isozymes I, II, and IX with triazole-linked O-glycosides of benzene sulfonamides. 174
Sildenafil is a strong activator of mammalian carbonic anhydrase isoforms I-XIV. 174
Carbonic anhydrase inhibitors: interactions of phenols with the 12 catalytically active mammalian isoforms (CA I-XIV). 174
Dithiocarbamates strongly inhibit the β-class carbonic anhydrases from Mycobacterium tuberculosis. 173
Structural insights on carbonic anhydrase inhibitory action, isoform selectivity, and potency of sulfonamides and coumarins incorporating arylsulfonylureido groups. 173
Inhibition of the β-carbonic anhydrase from the dandruff-producing fungus Malassezia globosa with monothiocarbamates 172
Cloning, expression, purification and sulfonamide inhibition profile of the complete domain of the η-carbonic anhydrase from Plasmodium falciparum 172
Cloning, characterization and anion inhibition studies of a new γ-carbonic anhydrase from the Antarctic bacterium Pseudoalteromonas haloplanktis 172
Carbonic anhydrase inhibitors: the first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX. 170
Reconstitution of carbonic anhydrase activity of the cell-surface-binding protein of vaccinia virus. 170
Design and synthesis of benzothiazole-6-sulfonamides acting as highly potent inhibitors of carbonic anhydrase isoforms I, II, IX and XII 170
Metallocene-based inhibitors of cancer-associated carbonic anhydrase enzymes IX and XII. 169
Inhibition of β-carbonic anhydrases with ureido-substituted benzenesulfonamides. 169
Poly(amidoamine) dendrimers with carbonic anhydrase inhibitory activity and antiglaucoma action 169
Carbonic anhydrase inhibitors: synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with sulfonamides derived from 4-isothiocyanato-benzolamide. 169
Benzenesulfonamides incorporating bulky aromatic/heterocyclic tails with potent carbonic anhydrase inhibitory activity 169
A Series of Thiadiazolyl-Benzenesulfonamides Incorporating an Aromatic Tail as Isoform-Selective, Potent Carbonic Anhydrase II/XII Inhibitors 168
Carbonic anhydrase activators: an activation study of the human mitochondrial isoforms VA and VB with amino acids and amines. 168
The first activation study of a bacterial carbonic anhydrase (CA). The thermostable α-CA from Sulfurihydrogenibium yellowstonense YO3AOP1 is highly activated by amino acids and amines. 168
Cloning, characterization and anion inhibition studies of a γ-carbonic anhydrase from the Antarctic bacterium Colwellia psychrerythraea 168
A new way of synthesizing heterocyclic primary sulfonamide probes for carbonic anhydrase 167
Carbonic anhydrase inhibitors: inhibition of the cytosolic human isozyme VII with anions. 167
Inhibition of carbonic anhydrases with glycosyltriazole benzene sulfonamides. 167
Identification of potent and selective human carbonic anhydrase VII (hCA VII) inhibitors. 166
Inhibition of carbonic anhydrase isozymes with benzene sulfonamides incorporating thio, sulfinyl and sulfonyl glycoside moieties. 166
Design, synthesis, and evaluation of hydroxamic acid derivatives as promising agents for the management of Chagas disease 166
Synthesis and carbonic anhydrase inhibitory properties of sulfamides structurally related to dopamine 166
Synthesis of C-cinnamoyl glycosides and their inhibitory activity against mammalian carbonic anhydrases. 166
Discovery of New Potential Anti-Infective Compounds Based on Carbonic Anhydrase Inhibitors by Rational Target-Focused Repurposing Approaches 166
Carbonic anhydrase activators: activation of the human tumor-associated isozymes IX and XII with amino acids and amines. 165
Poly(amidoamine) dendrimers show carbonic anhydrase inhibitory activity against α-, β-, γ- and η-class enzymes 165
Carbonic anhydrase inhibitors: novel sulfonamides incorporating 1,3,5-triazine moieties as inhibitors of the cytosolic and tumour-associated carbonic anhydrase isozymes I, II and IX. 164
Carbonic anhydrase inhibitors. The mitochondrial isozyme VB as a new target for sulfonamide and sulfamate inhibitors. 163
Carbonic anhydrase inhibitors. Inhibition of transmembrane isozymes XII (cancer-associated) and XIV with anions. 163
Carbonic anhydrase inhibitors. Diazenylbenzenesulfonamides are potent and selective inhibitors of the tumor-associated isozymes IX and XII over the cytosolic isoforms I and II. 163
Totale 20.153
Salva come PNG Salva come JPEG
Categoria #
all - tutte 136.599
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 136.599
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20222.025 90 215 276 52 50 98 110 171 70 95 208 590
2022/20234.119 610 1.103 82 213 285 745 449 146 283 49 101 53
2023/20241.198 79 165 334 57 72 145 38 181 24 40 35 28
2024/20259.793 394 1.108 704 1.288 3.135 908 142 494 708 312 277 323
2025/202613.882 973 1.852 1.171 1.502 1.261 640 1.598 842 866 753 355 2.069
2026/2027482 482 0 0 0 0 0 0 0 0 0 0 0
Totale 49.784